314 related articles for article (PubMed ID: 30518103)
1. Perturbing the Dynamics and Organization of Cell Membrane Components: A New Paradigm for Cancer-Targeted Therapies.
Bernardes N; Fialho AM
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518103
[TBL] [Abstract][Full Text] [Related]
2. Functional link between plasma membrane spatiotemporal dynamics, cancer biology, and dietary membrane-altering agents.
Erazo-Oliveras A; Fuentes NR; Wright RC; Chapkin RS
Cancer Metastasis Rev; 2018 Sep; 37(2-3):519-544. PubMed ID: 29860560
[TBL] [Abstract][Full Text] [Related]
3. Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance.
Gao Y; Shen JK; Milane L; Hornicek FJ; Amiji MM; Duan Z
Curr Med Chem; 2015; 22(11):1335-47. PubMed ID: 25666804
[TBL] [Abstract][Full Text] [Related]
4. Membrane rafts as a novel target in cancer therapy.
Hryniewicz-Jankowska A; Augoff K; Biernatowska A; Podkalicka J; Sikorski AF
Biochim Biophys Acta; 2014 Apr; 1845(2):155-65. PubMed ID: 24480320
[TBL] [Abstract][Full Text] [Related]
5. Biophysics in cancer: The relevance of drug-membrane interaction studies.
Alves AC; Ribeiro D; Nunes C; Reis S
Biochim Biophys Acta; 2016 Sep; 1858(9):2231-2244. PubMed ID: 27368477
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance and apoptosis in cancer treatment: development of new apoptosis-inducing agents active in drug resistant malignancies.
Tolomeo M; Simoni D
Curr Med Chem Anticancer Agents; 2002 May; 2(3):387-401. PubMed ID: 12678739
[TBL] [Abstract][Full Text] [Related]
7. Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer.
Bakare OO; Gokul A; Wu R; Niekerk LA; Klein A; Keyster M
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439786
[TBL] [Abstract][Full Text] [Related]
8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells.
Alimbetov D; Askarova S; Umbayev B; Davis T; Kipling D
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882812
[TBL] [Abstract][Full Text] [Related]
10. Antitumor Lipids--Structure, Functions, and Medical Applications.
Kostadinova A; Topouzova-Hristova T; Momchilova A; Tzoneva R; Berger MR
Adv Protein Chem Struct Biol; 2015; 101():27-66. PubMed ID: 26572975
[TBL] [Abstract][Full Text] [Related]
11. The amphiphilic nature of saponins and their effects on artificial and biological membranes and potential consequences for red blood and cancer cells.
Lorent JH; Quetin-Leclercq J; Mingeot-Leclercq MP
Org Biomol Chem; 2014 Nov; 12(44):8803-22. PubMed ID: 25295776
[TBL] [Abstract][Full Text] [Related]
12. Lipids as a target for drugs modulating multidrug resistance of cancer cells.
Hendrich AB; Michalak K
Curr Drug Targets; 2003 Jan; 4(1):23-30. PubMed ID: 12528987
[TBL] [Abstract][Full Text] [Related]
13. Current view on the mechanism of action of perifosine in cancer.
Fensterle J; Aicher B; Seipelt I; Teifel M; Engel J
Anticancer Agents Med Chem; 2014 May; 14(4):629-35. PubMed ID: 24628236
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics.
Gaspar D; Freire JM; Pacheco TR; Barata JT; Castanho MA
Biochim Biophys Acta; 2015 Feb; 1853(2):308-16. PubMed ID: 25447543
[TBL] [Abstract][Full Text] [Related]
15. Molecular Targets, Anti-cancer Properties and Potency of Synthetic Indole-3-carbinol Derivatives.
Karimabad MN; Mahmoodi M; Jafarzadeh A; Darekordi A; Hajizadeh MR; Hassanshahi G
Mini Rev Med Chem; 2019; 19(7):540-554. PubMed ID: 30444199
[TBL] [Abstract][Full Text] [Related]
16. Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy.
Choromańska A; Chwiłkowska A; Kulbacka J; Baczyńska D; Rembiałkowska N; Szewczyk A; Michel O; Gajewska-Naryniecka A; Przystupski D; Saczko J
Molecules; 2021 Mar; 26(7):. PubMed ID: 33806009
[TBL] [Abstract][Full Text] [Related]
17. [Apoptosis-reactivating agents for targeted anticancer therapy].
Fil'chenkov AA
Biomed Khim; 2013; 59(2):119-43. PubMed ID: 23789342
[TBL] [Abstract][Full Text] [Related]
18. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate C; Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):509-27. PubMed ID: 24628241
[TBL] [Abstract][Full Text] [Related]
19. Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy.
Gao M; Zhou J; Su Z; Huang Y
Protein Sci; 2017 Dec; 26(12):2334-2341. PubMed ID: 28960574
[TBL] [Abstract][Full Text] [Related]
20. Novel Insights into Membrane Targeting of B Cell Lymphoma.
de Winde CM; Elfrink S; van Spriel AB
Trends Cancer; 2017 Jun; 3(6):442-453. PubMed ID: 28718418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
